Methodology
PRS
ONCOLOGY, BREAST
The study was a randomized clinical trial. This trial was registered at ClinicalTrial.gov PRS under trial number NCT05463185 on date 18/07/2022. The study was started after approval from the ethical research committee of Riphah International University, Lahore Campus, Pakistan, with the reference number REC/RCR & AHS/22/0511. The data were collected at the Allied Hospital (Oncology ward, Breast Clinic and Physiotherapy ward), Faisalabad. The epitool software calculated the sample size of 36 after adding a 10% attrition rate [